Last Updated：2025/11/21
The clinical trial tested a monoclonal antibody designed to neutralize the inflammatory cytokine in patients with severe asthma.
See correct answer
The clinical trial tested a monoclonal antibody designed to neutralize the inflammatory cytokine in patients with severe asthma.
音声機能が動作しない場合はこちらをご確認ください
Edit Histories（0）
